rp 73401 has been researched along with colforsin in 2 studies
Studies (rp 73401) | Trials (rp 73401) | Recent Studies (post-2010) (rp 73401) | Studies (colforsin) | Trials (colforsin) | Recent Studies (post-2010) (colforsin) |
---|---|---|---|---|---|
92 | 0 | 23 | 13,460 | 46 | 1,298 |
Protein | Taxonomy | rp 73401 (IC50) | colforsin (IC50) |
---|---|---|---|
nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 1.729 | |
5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.041 | |
Adenylate cyclase type 1 | Homo sapiens (human) | 0.0955 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ezeamuzie, CI | 1 |
Kedia, GT; Kuczyk, MA; Merseburger, AS; Polat, H; Ückert, S | 1 |
2 other study(ies) available for rp 73401 and colforsin
Article | Year |
---|---|
Requirement of additional adenylate cyclase activation for the inhibition of human eosinophil degranulation by phosphodiesterase IV inhibitors.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Adult; Albuterol; Benzamides; Cell Degranulation; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Activation; Eosinophil Peroxidase; Eosinophils; Histamine; Humans; Nitriles; Peroxidases; Phosphodiesterase Inhibitors; Pyridines; Rolipram; Superoxides; Theophylline | 2001 |
Evaluating the significance of cyclic adenosine monophosphate-mediated signaling in human prostate: a functional and biochemical study.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Aged; Benzamides; Colforsin; Cyclic AMP; Humans; In Vitro Techniques; Inhibitory Concentration 50; Male; Middle Aged; Muscle Contraction; Muscle, Smooth; Papaverine; Phosphodiesterase 4 Inhibitors; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Prostate; Purines; Pyridines; Rolipram; Signal Transduction; Sildenafil Citrate; Sulfones | 2012 |